Literature DB >> 19055411

Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics.

Florian Nigsch1, Andreas Bender, Jeremy L Jenkins, John B O Mitchell.   

Abstract

We compared two algorithms for ligand-target prediction, namely, the Laplacian-modified Bayesian classifier and the Winnow algorithm. A dataset derived from the WOMBAT database, spanning 20 pharmaceutically relevant activity classes with 13 000 compounds, was used for performance assessment in 24 different experiments, each of which was assessed using a 15-fold Monte Carlo cross-validation. Compounds were described by different circular fingerprints, ECFP_4 and MOLPRINT 2D. A detailed analysis of the resulting approximately 2.4 million predictions led to very similar measures for overall accuracy for both classifiers, whereas we observed significant differences for individual activity classes. Moreover, we analyzed our data with respect to the numbers of compounds which are exclusively retrieved by either of the algorithmsbut never by the otheror by neither of them. This provided detailed information that can never be obtained by considering the overall performance statistics alone.

Mesh:

Substances:

Year:  2008        PMID: 19055411     DOI: 10.1021/ci800079x

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  30 in total

1.  Predicting DPP-IV inhibitors with machine learning approaches.

Authors:  Jie Cai; Chanjuan Li; Zhihong Liu; Jiewen Du; Jiming Ye; Qiong Gu; Jun Xu
Journal:  J Comput Aided Mol Des       Date:  2017-02-02       Impact factor: 3.686

2.  Drug discovery: Predicting promiscuity.

Authors:  Andrew L Hopkins
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

3.  LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.

Authors:  Minghao Zheng; Zhihong Liu; Xin Yan; Qianzhi Ding; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

4.  Predicting targets of compounds against neurological diseases using cheminformatic methodology.

Authors:  Katarina Nikolic; Lazaros Mavridis; Oscar M Bautista-Aguilera; José Marco-Contelles; Holger Stark; Maria do Carmo Carreiras; Ilaria Rossi; Paola Massarelli; Danica Agbaba; Rona R Ramsay; John B O Mitchell
Journal:  J Comput Aided Mol Des       Date:  2014-11-26       Impact factor: 3.686

5.  Predicting new molecular targets for known drugs.

Authors:  Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2009-11-01       Impact factor: 49.962

6.  Network-based relating pharmacological and genomic spaces for drug target identification.

Authors:  Shiwen Zhao; Shao Li
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

7.  Identification of anticancer drug target genes using an outside competitive dynamics model on cancer signaling networks.

Authors:  Tien-Dzung Tran; Duc-Tinh Pham
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

8.  Predicting the mechanism of phospholipidosis.

Authors:  Robert Lowe; Hamse Y Mussa; Florian Nigsch; Robert C Glen; John Bo Mitchell
Journal:  J Cheminform       Date:  2012-01-26       Impact factor: 5.514

9.  Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study.

Authors:  Lun Yang; Kejian Wang; Jian Chen; Anil G Jegga; Heng Luo; Leming Shi; Chunling Wan; Xizhi Guo; Shengying Qin; Guang He; Guoyin Feng; Lin He
Journal:  PLoS Comput Biol       Date:  2011-03-31       Impact factor: 4.475

10.  Fast rule-based bioactivity prediction using associative classification mining.

Authors:  Pulan Yu; David J Wild
Journal:  J Cheminform       Date:  2012-11-23       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.